Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo

Yaoxue Xuebao

Volumn 42, Issue 8, 2007, Pages 886-891

  Quan, Dong Qin ^a   Xu, Gui Xia ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Puerarin; Self emulsifying; Surfactant

Indexed keywords

EMULSIFYING AGENT; ISOFLAVONE DERIVATIVE; OLEIC ACID; POLYSORBATE; PROPANEDIOL DERIVATIVE; PUERARIN; SURFACTANT; VASODILATOR AGENT;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD; CHEMISTRY; DOG; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EMULSION; MALE; METHODOLOGY; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; SOLUBILITY;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; DOGS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EMULSIFYING AGENTS; EMULSIONS; ISOFLAVONES; MALE; OLEIC ACID; PARTICLE SIZE; POLYSORBATES; PROPYLENE GLYCOLS; SOLUBILITY; SURFACE-ACTIVE AGENTS; VASODILATOR AGENTS;

EID: 42149188225     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Robinson JR. Introduction; semi-solid formulations for oral drug delivery [J]. Bull Tech Gattefosse, 1996, 89:11-13.
2. Aungst BJ. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism [J]. J Pharm Sci, 1993, 82:979-987.
3. Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs [J]. Eur J Pharm Biopharm, 2000, 50:179-188.
4. Khoo SM, Humberstone AJ, Charman WN. Formulation design and bioavailability assessment of lipidie self-emulsifying formulations of halofantrine [J]. Int J Pharm, 1998, 167:155-164.
5. Kim JY, Ku YS. Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats [J]. Int J Pharm, 2000, 194:81-89.
6. Kommuru TR, Gurley B, Reddy IK, et al. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10; formulation development and bioavailability assessment [J]. Int J Pharm, 2001, 212:233-246.
7. Nazzal S, Smalyukh II, Khan MA, et al. Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation [J]. Int J Pharm, 2002, 235:247-265.
8. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs [J]. Biomed Pharmacother, 2004, 58:173-182.
9. Du LJ, Yu L, Si JY, et al. Pharmacokinetics of pueraia flavanoids by new technological process [J]. Chin Med Pharmaco Clinic, 1997, 13:93-96.
10. Chen J, Lin H, Hu M. Metabolism of flavonoids via enteric recycling: role of intestinal disposition [J]. J Pharmacol Exp Ther, 2003, 304;1228-1235.
11. Y L, Pan WS, Xu HX, et al. Studies on preparation of phospholipid- puerarin complex and its solid dispersion [J]. Chin Phram J, 2006, 41:104-106.
12. Craig DQM. The use of self-emulsifying systems as a means of improving drug delivery [J]. Bull Tech Gattefosse, 1993, 86:21-31.
13. Zhang ZR, You XJ, He Q, et al. Determination of puerarin in plasma by HPLC [J]. Chin Pharm J, 1997, 32:104-106.
14. Craig DQM, Barker SA, Booth SW, et al. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy [J]. Int J Pharm, 1995, 114:103 -110.
15. Pouton CW. Formulation of self-emulsifying drug delivery systems [J]. Adv Drug Del Rev, 1997, 25:47-58.
16. Gao P, Witt MJ, Haskell RJ, et al. Application of a mixture experimental design in the optimization of a self-emulsifying formulation with a high drug load [J]. Pharm Dev Technol, 2004, 9:301-309.
17. Poelma FG, Breas R, Tukker JJ. Intestinal absorption of drugs. III. The influence of taurocholate on the disappearance kinetics of hydrophilic and lipophilic drugs from the small intestine of the rat [J]. Pharm Res, 1990, 7:392-397.
18. Chiu YY, Higaki K, Amidon GL, et al. Human jejunal permeability of cyclosporin A: influence of surfactants on P-glycoprotein efflux in Caco-2 cells [J]. Pharm Res, 2003, 20:749-756.